GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of speciality medicines including cancer and HIV drugs, sending shares up as much as 6 per cent on ...

Growth in regular pay, excluding bonuses, was also strong in December rising to 2.7 per cent, from 2.5 per cent in November. Growth in pay is expected to remain robust this year with a 3 per cent rise ...

Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations.

Santander has reported higher profits in the UK as the future of its business in the country remains in doubt. The Spanish ...

In the context of China’s broader challenges, this all makes sense. Its economy is struggling. Its leaders want to avoid US ...

Can Jens Stoltenberg tame the US president once again?

Also in today’s newsletter, Microsoft poaches DeepMind staff behind AI podcasting feature, and FBI agents sue Trump ...

Yet when Irish architects Sheila O’Donnell and John Tuomey are chatting about the spaces in their new Sadler’s Wells East ...

Waves of departures for jobs abroad and a low birth rate have emptied Bulgaria’s villages. The social fabric is at stake ...

Like many an SW1 woman in the 1990s, the champagne-swilling, Lacroix-wearing protagonists of Absolutely Fabulous were ...

The tool, which was drawn up during Trump’s first term and subsequently used as a deterrent against China, allows the EU’s ...

Clothes can be a source of comfort — and restore a sense of self — to those who have lost their belongings as a result of ...